← European Medicine Shortage Tracker · all medicines

Entakapon, karbidopa (monohydrat), levodopa shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Entakapon, karbidopa (monohydrat), levodopa currently has availability issues reported in 2 European registers: Spain, Sweden.

Shortage  ATC — · also listed as: LEVODOPA CARBIDOPA ENTACAPONA · entakapon, karbidopa (monohydrat), levodopa · data refreshed 13 September 2026

Key facts

As of 13 September 2026, 2 of the 9 tracked registers list current availability issues for Entakapon, karbidopa (monohydrat), levodopa, covering 5 affected product presentations. The longest-running open report was filed in Spain on 2026-05-28 and has now been open for about 4 months. The furthest expected-resolution date currently on file is 2026-10-29; the earliest is 2026-10-15. Notably, 3 reports have already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 4 of the open reports were filed within the last 90 days. Registers in Spain, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇪🇸 SpainShortage
LEVODOPA/CARBIDOPA/ENTACAPONA CINFA 50 MG/12,5 MG/200MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 100 comprimidos
+ 1 more products
LEVODOPA/CARBIDOPA/ENTACAPONA KERN PHARMA 200 mg /50 mg /200 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG , 100 comprimidos
2026-05-282026-10-29Existen otros medicamentos con los mismos principios activos y misma vía.
Alternatives: Existe/n otro/s medicamento/s con los mismos principios activos y para la misma vía de administración.
register ↗
🇸🇪 SwedenShortage
Levodopa/Carbidopa/Entacapone Orion 150 mg/37,5 mg/200 mg Filmdragerad tablett
+ 2 more products
Levodopa/Carbidopa/Entacapone Orion 150 mg/37,5 mg/200 mg Filmdragerad tablett
Stalevo 175 mg/43,75 mg/200 mg Filmdragerad tablett
2026-06-222026-08-31
Alternatives: Alternative(s) available — see the national register.
register ↗

New register reports per month

2026-05: 12026-06: 12026-07: 12026-08: 12026-09: 12026-052026-09

Full report history (5 register entries)

Every individual register entry for Entakapon, karbidopa (monohydrat), levodopa in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇪🇸 ESLEVODOPA/CARBIDOPA/ENTACAPONA KERN PHARMA 200 mg /50 mg /200 mg COMPRIShortage2026-09-092026-10-29Existen otros medicamentos con los mismos principios activos
🇸🇪 SELevodopa/Carbidopa/Entacapone Orion 150 mg/37,5 mg/200 mg FilmdrageradExpected shortage2026-08-172026-08-31
🇸🇪 SELevodopa/Carbidopa/Entacapone Orion 150 mg/37,5 mg/200 mg FilmdrageradShortage2026-07-062026-07-27
🇸🇪 SEStalevo 175 mg/43,75 mg/200 mg Filmdragerad tablettShortage2026-06-222026-07-27
🇪🇸 ESLEVODOPA/CARBIDOPA/ENTACAPONA CINFA 50 MG/12,5 MG/200MG COMPRIMIDOS REShortage2026-05-282026-10-15Existen otros medicamentos con los mismos principios activos

Frequently asked

Is Entakapon, karbidopa (monohydrat), levodopa currently in shortage in Europe?

Yes. As of 13 September 2026, availability issues are reported in: Spain, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Entakapon, karbidopa (monohydrat), levodopa shortage expected to end?

Agency prognoses on file range from 2026-10-15 to 2026-10-29. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Entakapon, karbidopa (monohydrat), levodopa?

5 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Entakapon, karbidopa (monohydrat), levodopa availability data come from?

Directly from the official medicines-agency registers that list Entakapon, karbidopa (monohydrat), levodopa: AEMPS CIMA (Spain), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Entakapon, karbidopa (monohydrat), levodopa — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/entakapon-karbidopa-monohydrat-levodopa/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Entakapon, karbidopa (monohydrat), levodopa availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/entakapon-karbidopa-monohydrat-levodopa/">Entakapon, karbidopa (monohydrat), levodopa shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Entakapon, karbidopa (monohydrat), levodopa: availability status across 2 European registers — European Medicine Shortage Tracker (MobiDoctor), 13 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.